Evidence map›Paper›PMID 27485357›Full record

ArticleThe Journal of infectious diseases2016

Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.

Lene Ryom, Jens D Lundgren, Mike Ross, Ole Kirk, Matthew Law, Philippe Morlat, Eric Fontas, Colette Smit, Christoph A Fux, Camilla I Hatleberg and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Examining Depression as a Risk Factor for Cardiovascular Disease in People with HIV: A Systematic Review.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2023
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Observational
  18. Review
  19. Observational
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 8 countries.

Lene RyomDepartment of Infectious Diseases, CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Denmark.
Jens D LundgrenDepartment of Infectious Diseases, CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Denmark.
Mike RossDivision of Nephrology, Mount Sinai School of Medicine, New York.
Ole KirkDepartment of Infectious Diseases, CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Denmark.
Matthew LawKirby Institute, University of New South Wales, Sydney, Australia.
Philippe MorlatUniversité Bordeaux, INSERM U 897, CHU de Bordeaux.
Eric FontasNephrology Department, Public Health Department, CHU Nice, France.
Colette SmitAcademic Medical Center, Division of Infectious Diseases Department of Global Health, University of Amsterdam HIV Monitoring Foundation, Amsterdam, The Netherlands.
Christoph A FuxClinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.
Camilla I HatlebergDepartment of Infectious Diseases, CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Denmark.
Stéphane de WitDepartment of Infectious Diseases, CHU Saint-Pierre, Brussels, Belgium.
Caroline A SabinResearch Department of Infection and Population Health, University College London, United Kingdom.
Amanda MocroftResearch Department of Infection and Population Health, University College London, United Kingdom.
D:A:D Study Group
Rigshospitalet · DKUniversity College London · GBUniversity of Copenhagen · DKCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Saint-Pierre · BEIcahn School of Medicine at Mount Sinai · USKantonsspital Aarau · CHUniversity of Amsterdam · NLUNSW Sydney · AU

Funding

COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDSU01AI046362 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI GORDIN, FRED M · 2000 to 2006
$75.9M
The Asia-Pacific HIV Research CollaborationU01AI069907 · NIAID · FOUNDATION FOR AIDS RESEARCH · PI ANNETTE H SOHN · 2006 to 2026
$44.8M
TERRY BEIRN COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ONU01AI042170 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NEATON, JAMES DENNIS · 1997 to 2006
$23.2M
Novel mechanisms of antiretroviral protection against HIV-related kidney diseasesR01DK101338 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ROSS, MICHAEL J · 2014 to 2018
$1.9M
The role of APOL1 polymorphisms in promoting HIV-related kidney injuryR01DK108346 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ROSS, MICHAEL J · 2015 to 2019
$1.6M
NIAID NIH HHS U01 AI042170NIAID NIH HHS U01 AI046362NIAID NIH HHS U01 AI069907NIDDK NIH HHS R01 DK108346
6 · The paper itself

Abstract

backgroundWhile the association between renal impairment and cardiovascular disease (CVD) is well established in the general population, the association remains poorly understood in human immunodeficiency virus (HIV)-positive individuals.

methodsIndividuals with ≥2 estimated glomerular filtration rate (eGFR) measurements after 1 February 2004 were followed until CVD, death, last visit plus 6 months, or 1 February 2015. CVD was defined as the occurrence of centrally validated myocardial infarction, stroke, invasive cardiovascular procedures, or sudden cardiac death.

resultsDuring a median follow-up duration of 8.0 years (interquartile range, 5.4-8.9 years) 1357 of 35 357 individuals developed CVD (incidence rate, 5.2 cases/1000 person-years [95% confidence interval {CI}, 5.0-5.5]). Confirmed baseline eGFR and CVD were closely related with 1.8% of individuals (95% CI, 1.6%-2.0%) with an eGFR > 90 mL/minute/1.73 m(2) estimated to develop CVD at 5 years, increasing to 21.1% (95% CI, 6.6%-35.6%) among those with an eGFR ≤ 30 mL/minute/1.73 m(2) The strong univariate relationship between low current eGFR and CVD was primarily explained by increasing age in adjusted analyses, although all eGFRs ≤ 80 mL/minute/1.73 m(2) remained associated with 30%-40% increased CVD rates, and particularly high CVD rates among individuals with an eGFR ≤ 30 mL/minute/1.73 m(2) (incidence rate ratio, 3.08 [95% CI, 2.04-4.65]).

conclusionsAmong HIV-positive individuals in a large contemporary cohort, a strong relation between confirmed impaired eGFR and CVD was observed. This finding highlights the need for renal preventive measures and intensified monitoring for emerging CVD, particularly in older individuals with continuously low eGFRs.

Indexed as

AdultCardiovascular DiseasesFemaleGlomerular Filtration RateHIV InfectionsHumansKidneyMaleMiddle AgedMyocardial InfarctionProspective StudiesRenal InsufficiencyRisk FactorsStrokecardiovascular diseaseeGFRHIVinvasive cardiovascular procedureskidney diseasemyocardial infarctionrenal impairmentstrokesudden cardiac death

Identifiers

PMID27485357
PMCPMC5034954
OpenAlexW2483588435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.